Clinical Immunology Society

CIS/Grifols AIM Program

CIS-Grifols AIM 2026: Advancing Immunologists through Mentorship & Collaboration

 

A Strategic Workshop to Build Professional Readiness and Collaborative Capacity

 

  • In today’s evolving research and therapeutic landscape, industry-academic partnerships are essential for driving innovation and expanding patient access to care and improved outcomes
  • The CIS-Grifols AIM Program is a strategic collaboration between Grifols, a global leader in plasma-derived therapies, and CIS to further advance support for the field of Immunology
  • This initiative is designed to empower new-to-practice immunologists with the tools, insights, and connections needed to thrive in academic, clinic and industry settings

AIM Program Target

Program Goals

  • Equip early-career immunologists with strategic frameworks for professional growth
  • Enhance readiness for collaborative roles in therapeutic development
  • Build confidence in navigating career pathways for Immunologists
   

 

What You'll Gain by Attending

 

Mentorship
Gain direct access to seasoned CIS Faculty and Industry mentors who offer personalized guidance, share real-world collaboration experiences, and help shape your strategic approach to your career development and innovation.
 
Professional Development Deep Dive
Participate in hands-on sessions to sharpen your strategic edge:

Ivy Lee Method for time management/productivity and prioritization

SWOT/TOWS Matrix Analysis to assess and align your professional trajectory
LinkedIn Optimization to enhance visibility and networking impact
Conference Attendance Strategy to maximize engagement and elevate your presence for collaborations
 
Participate in “ImmunoVate”

     A critical review of innovative ideas for a development session through Idea Incubator with faculty experts in the field

 

Explore Collaboration Pathways
Learn how to position and prepare your infrastructure, and how to communicate your value
 
Industry Career Spotlights
Hear directly from pharma industry leaders including:
•Christina Hill-Zabala, PharmD, MBA – North America Medical Affairs Senior Director
•Dan Adelman, MD – Chief Medical Officer and Drug Development Expert
 
Behind-the-Scenes Access
Gain insights into manufacturing and product development processes to better understand how therapies move from bench to bedside, or in the case of plasma derived therapies, vein to vein
 

Application Requirements

Individuals who are interested in attending the program must submit the following materials as their application.

  • A CV, no more than four (4) pages
  • A brief statement of interest regarding the field of clinical immunology.
  • Submission of an idea for a clinical trial to be pitched in our IMmunoVate shark-tank like experience.
top